A detailed history of Invesco, LLC transactions in Amgen Inc stock. As of the latest transaction made, Invesco, LLC holds 11,389 shares of AMGN stock, worth $3.3 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
11,389
Previous 11,380 0.08%
Holding current value
$3.3 Million
Previous $3.56 Billion 3.21%
% of portfolio
1.46%
Previous 1.49%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$309.38 - $337.38 $2,784 - $3,036
9 Added 0.08%
11,389 $3.67 Billion
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $1,344 - $1,622
-5 Reduced 0.04%
11,380 $3.24 Billion
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $255 - $288
-1 Reduced 0.01%
11,385 $3.28 Billion
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $8,746 - $10,858
-40 Reduced 0.35%
11,386 $3.06 Billion
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $2.45 Million - $2.9 Million
11,426 New
11,426 $2.54 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Invesco, LLC Portfolio

Follow Invesco, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invesco, LLC with notifications on news.